| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Notch binding | 5.42e-15 | 27 | 29 | 7 | GO:0005112 | |
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B AGRN NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.70e-14 | 749 | 29 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.36e-07 | 85 | 29 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.52e-06 | 16 | 29 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.60e-06 | 21 | 29 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.93e-06 | 188 | 29 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 7.87e-06 | 27 | 29 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.83e-05 | 891 | 29 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 5.47e-05 | 51 | 29 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | integrin binding | 1.14e-04 | 175 | 29 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 8.07e-04 | 29 | 29 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.46e-03 | 39 | 29 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.98e-03 | 173 | 29 | 3 | GO:0008083 | |
| GeneOntologyBiologicalProcess | axon development | SCARF1 LRP1 LRP2 LAMA3 LAMB1 LAMC3 KREMEN1 TNC AGRN NOTCH1 NOTCH2 | 5.07e-10 | 642 | 29 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | axon guidance | 4.02e-09 | 285 | 29 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.13e-09 | 286 | 29 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | aorta development | 8.54e-08 | 80 | 29 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SCARF1 LAMA3 LAMB1 ITGB7 MEGF11 MEGF10 NOTCH1 JAG1 NOTCH4 CRB1 CELA2A | 1.08e-07 | 1077 | 29 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.73e-07 | 92 | 29 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | neuron development | SCARF1 LRP1 LRP2 LAMA3 LAMB1 LAMC3 KREMEN1 TNC AGRN NOTCH1 NOTCH2 CRB1 | 2.58e-07 | 1463 | 29 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 2.94e-07 | 927 | 29 | 10 | GO:0030155 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 3.08e-07 | 41 | 29 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 LRP2 LAMA3 LAMB1 LAMC3 TNC MEGF11 NOTCH1 NOTCH2 JAG1 CRB1 | 5.65e-07 | 1269 | 29 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | neuron projection development | SCARF1 LRP1 LRP2 LAMA3 LAMB1 LAMC3 KREMEN1 TNC AGRN NOTCH1 NOTCH2 | 6.41e-07 | 1285 | 29 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell fate determination | 6.94e-07 | 50 | 29 | 4 | GO:0001709 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.90e-07 | 566 | 29 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | artery development | 1.08e-06 | 133 | 29 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.12e-06 | 134 | 29 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.55e-06 | 619 | 29 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.85e-06 | 435 | 29 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | axon regeneration | 2.56e-06 | 69 | 29 | 4 | GO:0031103 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.80e-06 | 20 | 29 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.96e-06 | 1194 | 29 | 10 | GO:0000902 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.73e-06 | 171 | 29 | 5 | GO:0048593 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 4.63e-06 | 80 | 29 | 4 | GO:2000179 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 4.86e-06 | 81 | 29 | 4 | GO:0031102 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 4.96e-06 | 24 | 29 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 5.72e-06 | 3 | 29 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.28e-06 | 748 | 29 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 6.41e-06 | 750 | 29 | 8 | GO:0048729 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 7.08e-06 | 89 | 29 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 7.82e-06 | 199 | 29 | 5 | GO:0051147 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 7.99e-06 | 28 | 29 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 8.82e-06 | 204 | 29 | 5 | GO:0048592 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.02e-05 | 210 | 29 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.05e-05 | 802 | 29 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.06e-05 | 212 | 29 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.14e-05 | 4 | 29 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.16e-05 | 375 | 29 | 6 | GO:0007162 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.22e-05 | 819 | 29 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.30e-05 | 826 | 29 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | response to axon injury | 1.37e-05 | 105 | 29 | 4 | GO:0048678 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 1.42e-05 | 106 | 29 | 4 | GO:0051149 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.89e-05 | 114 | 29 | 4 | GO:0008593 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.90e-05 | 5 | 29 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.90e-05 | 5 | 29 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.92e-05 | 410 | 29 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.23e-05 | 421 | 29 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.38e-05 | 426 | 29 | 6 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 2.38e-05 | 40 | 29 | 3 | GO:0048679 | |
| GeneOntologyBiologicalProcess | regeneration | 2.44e-05 | 252 | 29 | 5 | GO:0031099 | |
| GeneOntologyBiologicalProcess | response to wounding | 2.78e-05 | 659 | 29 | 7 | GO:0009611 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 2.85e-05 | 6 | 29 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 2.85e-05 | 6 | 29 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 2.85e-05 | 6 | 29 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 2.85e-05 | 6 | 29 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 2.85e-05 | 6 | 29 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 2.85e-05 | 6 | 29 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 3.67e-05 | 135 | 29 | 4 | GO:2000177 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 3.89e-05 | 47 | 29 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 3.89e-05 | 47 | 29 | 3 | GO:0070570 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 3.89e-05 | 47 | 29 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.99e-05 | 7 | 29 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 3.99e-05 | 7 | 29 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | eye development | 4.64e-05 | 480 | 29 | 6 | GO:0001654 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 4.68e-05 | 50 | 29 | 3 | GO:1905314 | |
| GeneOntologyBiologicalProcess | visual system development | 4.80e-05 | 483 | 29 | 6 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 5.26e-05 | 491 | 29 | 6 | GO:0048880 | |
| GeneOntologyBiologicalProcess | sensory organ development | 5.34e-05 | 730 | 29 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 5.58e-05 | 53 | 29 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 5.91e-05 | 54 | 29 | 3 | GO:0051150 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 6.83e-05 | 9 | 29 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 6.83e-05 | 9 | 29 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 6.83e-05 | 9 | 29 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 6.95e-05 | 57 | 29 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 7.29e-05 | 161 | 29 | 4 | GO:0003206 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 7.73e-05 | 321 | 29 | 5 | GO:0010001 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 8.53e-05 | 10 | 29 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 8.53e-05 | 10 | 29 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 8.53e-05 | 10 | 29 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 8.53e-05 | 10 | 29 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | distal tubule development | 8.53e-05 | 10 | 29 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 9.38e-05 | 63 | 29 | 3 | GO:0003179 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 9.72e-05 | 337 | 29 | 5 | GO:0006898 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 9.86e-05 | 338 | 29 | 5 | GO:0045165 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.06e-04 | 343 | 29 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.08e-04 | 817 | 29 | 7 | GO:0048514 | |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 1.13e-04 | 67 | 29 | 3 | GO:0042491 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.13e-04 | 67 | 29 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.17e-04 | 1125 | 29 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 1.23e-04 | 69 | 29 | 3 | GO:0030857 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.25e-04 | 1469 | 29 | 9 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.25e-04 | 12 | 29 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.47e-04 | 858 | 29 | 7 | GO:0061061 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.47e-04 | 13 | 29 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 1.51e-04 | 74 | 29 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.51e-04 | 74 | 29 | 3 | GO:0002011 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.62e-04 | 198 | 29 | 4 | GO:0048754 | |
| GeneOntologyBiologicalProcess | glomerulus development | 1.70e-04 | 77 | 29 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.72e-04 | 14 | 29 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 1.72e-04 | 14 | 29 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 1.72e-04 | 14 | 29 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.77e-04 | 78 | 29 | 3 | GO:0003170 | |
| GeneOntologyCellularComponent | basement membrane | 6.62e-07 | 122 | 29 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.16e-06 | 656 | 29 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.21e-06 | 658 | 29 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 6.22e-06 | 530 | 29 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 9.97e-06 | 212 | 29 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | axonal growth cone | 3.28e-05 | 45 | 29 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 7.41e-05 | 59 | 29 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin complex | 8.30e-05 | 10 | 29 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | receptor complex | 1.24e-04 | 581 | 29 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.68e-04 | 384 | 29 | 5 | GO:0030139 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.77e-04 | 79 | 29 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | adherens junction | 2.00e-04 | 212 | 29 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.49e-04 | 17 | 29 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | anchoring junction | 2.99e-04 | 976 | 29 | 7 | GO:0070161 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 3.06e-04 | 237 | 29 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.65e-04 | 101 | 29 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | cell surface | 6.54e-04 | 1111 | 29 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.09e-03 | 147 | 29 | 3 | GO:0030665 | |
| GeneOntologyCellularComponent | apical part of cell | 1.21e-03 | 592 | 29 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | coated vesicle | 1.46e-03 | 360 | 29 | 4 | GO:0030135 | |
| GeneOntologyCellularComponent | cell-substrate junction | 3.11e-03 | 443 | 29 | 4 | GO:0030055 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 3.22e-03 | 215 | 29 | 3 | GO:0030662 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.35e-03 | 487 | 29 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | growth cone | 4.64e-03 | 245 | 29 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 5.07e-03 | 253 | 29 | 3 | GO:0030427 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 5.49e-03 | 80 | 29 | 2 | GO:0005905 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 8.09e-03 | 1307 | 29 | 6 | GO:0030659 | |
| GeneOntologyCellularComponent | cell-cell junction | 8.57e-03 | 591 | 29 | 4 | GO:0005911 | |
| GeneOntologyCellularComponent | vesicle membrane | 8.64e-03 | 1325 | 29 | 6 | GO:0012506 | |
| MousePheno | increased cochlear hair cell number | 8.02e-06 | 20 | 28 | 3 | MP:0004407 | |
| MousePheno | abnormal sensory neuron morphology | 3.10e-05 | 473 | 28 | 7 | MP:0000965 | |
| MousePheno | increased sensory neuron number | 7.29e-05 | 41 | 28 | 3 | MP:0006006 | |
| MousePheno | abnormal cochlear labyrinth morphology | 9.22e-05 | 235 | 28 | 5 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 9.22e-05 | 235 | 28 | 5 | MP:0003169 | |
| MousePheno | abnormal cochlea morphology | 1.19e-04 | 248 | 28 | 5 | MP:0000031 | |
| MousePheno | abnormal cochlear outer hair cell number | 1.32e-04 | 50 | 28 | 3 | MP:0004400 | |
| MousePheno | abnormal membranous labyrinth morphology | 1.54e-04 | 262 | 28 | 5 | MP:0000035 | |
| MousePheno | abnormal inner ear morphology | 3.02e-04 | 303 | 28 | 5 | MP:0000026 | |
| MousePheno | abnormal cochlear hair cell number | 3.31e-04 | 68 | 28 | 3 | MP:0004406 | |
| MousePheno | increased cochlear inner hair cell number | 3.47e-04 | 14 | 28 | 2 | MP:0004395 | |
| MousePheno | abnormal somatic sensory system morphology | 3.66e-04 | 702 | 28 | 7 | MP:0000959 | |
| MousePheno | increased neuron number | 3.91e-04 | 72 | 28 | 3 | MP:0008947 | |
| MousePheno | abnormal bile duct development | 4.00e-04 | 15 | 28 | 2 | MP:0002929 | |
| MousePheno | increased cochlear outer hair cell number | 4.56e-04 | 16 | 28 | 2 | MP:0004401 | |
| MousePheno | abnormal retina horizontal cell morphology | 6.48e-04 | 19 | 28 | 2 | MP:0006068 | |
| MousePheno | abnormal somatic nervous system morphology | 6.72e-04 | 1025 | 28 | 8 | MP:0002752 | |
| Domain | EGF_1 | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 LRP1B TNC AGRN ITGB7 MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.64e-43 | 255 | 29 | 25 | PS00022 |
| Domain | EGF_2 | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 LRP1B TNC AGRN ITGB7 MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 4.49e-43 | 265 | 29 | 25 | PS01186 |
| Domain | EGF | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 LRP1B TNC AGRN MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 8.39e-42 | 235 | 29 | 24 | SM00181 |
| Domain | EGF-like_dom | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 LRP1B TNC AGRN MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 3.60e-41 | 249 | 29 | 24 | IPR000742 |
| Domain | EGF-like_CS | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 SNED1 LAMC3 EGF MEGF6 ADAM23 LRP1B TNC AGRN ITGB7 MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.17e-40 | 261 | 29 | 24 | IPR013032 |
| Domain | EGF_3 | SCARF1 JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 ADAM23 LRP1B TNC AGRN MEGF11 ATRNL1 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.97e-34 | 235 | 29 | 21 | PS50026 |
| Domain | Growth_fac_rcpt_ | SCARF1 JAG2 LRP1 LRP2 LAMA3 CRELD2 LAMB1 LAMC3 EGF MEGF6 LRP1B TNC NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 9.11e-29 | 156 | 29 | 17 | IPR009030 |
| Domain | EGF_CA | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B AGRN NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 4.96e-26 | 122 | 29 | 15 | SM00179 |
| Domain | EGF_extracell | SCARF1 JAG2 LRP2 MEGF6 ADAM23 LRP1B TNC ITGB7 MEGF11 ATRNL1 MEGF10 NOTCH1 JAG1 | 6.28e-26 | 60 | 29 | 13 | IPR013111 |
| Domain | EGF_2 | SCARF1 JAG2 LRP2 MEGF6 ADAM23 LRP1B TNC ITGB7 MEGF11 ATRNL1 MEGF10 NOTCH1 JAG1 | 6.28e-26 | 60 | 29 | 13 | PF07974 |
| Domain | EGF-like_Ca-bd_dom | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B AGRN NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 6.42e-26 | 124 | 29 | 15 | IPR001881 |
| Domain | EGF_Ca-bd_CS | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 2.84e-25 | 97 | 29 | 14 | IPR018097 |
| Domain | EGF_CA | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 3.85e-25 | 99 | 29 | 14 | PS01187 |
| Domain | ASX_HYDROXYL | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 4.48e-25 | 100 | 29 | 14 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 LRP1 LRP2 CRELD2 SNED1 OIT3 EGF MEGF6 LRP1B NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.07e-24 | 106 | 29 | 14 | IPR000152 |
| Domain | EGF | JAG2 LRP1 LRP2 SNED1 EGF MEGF6 LRP1B TNC AGRN NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.37e-23 | 126 | 29 | 14 | PF00008 |
| Domain | hEGF | JAG2 SNED1 MEGF6 MEGF11 MEGF10 NOTCH1 NOTCH2 JAG1 NOTCH4 CRB1 | 1.82e-22 | 28 | 29 | 10 | PF12661 |
| Domain | Laminin_EGF | SCARF1 LAMA3 CRELD2 LAMB1 LAMC3 MEGF6 AGRN MEGF11 ATRNL1 MEGF10 | 6.50e-21 | 38 | 29 | 10 | IPR002049 |
| Domain | EGF_CA | JAG2 LRP1 LRP2 CRELD2 EGF MEGF6 LRP1B NOTCH1 NOTCH2 JAG1 NOTCH4 | 3.29e-19 | 86 | 29 | 11 | PF07645 |
| Domain | Laminin_EGF | 2.68e-16 | 35 | 29 | 8 | PF00053 | |
| Domain | EGF_Lam | 2.68e-16 | 35 | 29 | 8 | SM00180 | |
| Domain | EGF_LAM_2 | 8.70e-10 | 30 | 29 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 8.70e-10 | 30 | 29 | 5 | PS01248 | |
| Domain | Ldl_recept_b | 4.64e-09 | 14 | 29 | 4 | PF00058 | |
| Domain | LDLRB | 4.64e-09 | 14 | 29 | 4 | PS51120 | |
| Domain | LY | 6.32e-09 | 15 | 29 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.32e-09 | 15 | 29 | 4 | IPR000033 | |
| Domain | NOD | 1.34e-08 | 4 | 29 | 3 | PF06816 | |
| Domain | Notch | 1.34e-08 | 4 | 29 | 3 | IPR008297 | |
| Domain | NODP | 1.34e-08 | 4 | 29 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 1.34e-08 | 4 | 29 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.34e-08 | 4 | 29 | 3 | IPR010660 | |
| Domain | NOD | 1.34e-08 | 4 | 29 | 3 | SM01338 | |
| Domain | NODP | 1.34e-08 | 4 | 29 | 3 | SM01339 | |
| Domain | LNR | 3.36e-08 | 5 | 29 | 3 | PS50258 | |
| Domain | Notch_dom | 1.17e-07 | 7 | 29 | 3 | IPR000800 | |
| Domain | Notch | 1.17e-07 | 7 | 29 | 3 | PF00066 | |
| Domain | NL | 1.17e-07 | 7 | 29 | 3 | SM00004 | |
| Domain | - | 3.71e-07 | 39 | 29 | 4 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.31e-07 | 46 | 29 | 4 | IPR011042 | |
| Domain | LAMININ_NTER | 1.86e-06 | 16 | 29 | 3 | PS51117 | |
| Domain | Laminin_N | 1.86e-06 | 16 | 29 | 3 | PF00055 | |
| Domain | EMI_domain | 1.86e-06 | 16 | 29 | 3 | IPR011489 | |
| Domain | Laminin_N | 1.86e-06 | 16 | 29 | 3 | IPR008211 | |
| Domain | LamNT | 1.86e-06 | 16 | 29 | 3 | SM00136 | |
| Domain | EMI | 2.26e-06 | 17 | 29 | 3 | PS51041 | |
| Domain | DUF5050 | 2.33e-06 | 2 | 29 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.33e-06 | 2 | 29 | 2 | PF16472 | |
| Domain | Jagged/Serrate | 2.33e-06 | 2 | 29 | 2 | IPR026219 | |
| Domain | DUF3454 | 6.98e-06 | 3 | 29 | 2 | PF11936 | |
| Domain | DUF3454_notch | 6.98e-06 | 3 | 29 | 2 | IPR024600 | |
| Domain | DUF3454 | 6.98e-06 | 3 | 29 | 2 | SM01334 | |
| Domain | cEGF | 8.54e-06 | 26 | 29 | 3 | IPR026823 | |
| Domain | cEGF | 8.54e-06 | 26 | 29 | 3 | PF12662 | |
| Domain | DSL | 1.39e-05 | 4 | 29 | 2 | PF01414 | |
| Domain | DSL | 1.39e-05 | 4 | 29 | 2 | SM00051 | |
| Domain | DSL | 2.32e-05 | 5 | 29 | 2 | IPR001774 | |
| Domain | DSL | 2.32e-05 | 5 | 29 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 2.32e-05 | 5 | 29 | 2 | IPR011651 | |
| Domain | MNNL | 2.32e-05 | 5 | 29 | 2 | PF07657 | |
| Domain | LAM_G_DOMAIN | 2.74e-05 | 38 | 29 | 3 | PS50025 | |
| Domain | LDLR_class-A_CS | 3.20e-05 | 40 | 29 | 3 | IPR023415 | |
| Domain | LamG | 4.27e-05 | 44 | 29 | 3 | SM00282 | |
| Domain | Ldl_recept_a | 4.57e-05 | 45 | 29 | 3 | PF00057 | |
| Domain | - | 4.88e-05 | 46 | 29 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.55e-05 | 48 | 29 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.91e-05 | 49 | 29 | 3 | IPR002172 | |
| Domain | LDLa | 5.91e-05 | 49 | 29 | 3 | SM00192 | |
| Domain | LDLRA_2 | 5.91e-05 | 49 | 29 | 3 | PS50068 | |
| Domain | LAMININ_IVA | 6.48e-05 | 8 | 29 | 2 | PS51115 | |
| Domain | Laminin_B | 6.48e-05 | 8 | 29 | 2 | PF00052 | |
| Domain | LamB | 6.48e-05 | 8 | 29 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.48e-05 | 8 | 29 | 2 | IPR000034 | |
| Domain | Laminin_G | 9.81e-05 | 58 | 29 | 3 | IPR001791 | |
| Domain | Fol_N | 1.27e-04 | 11 | 29 | 2 | IPR003645 | |
| Domain | FOLN | 1.27e-04 | 11 | 29 | 2 | SM00274 | |
| Domain | VWC_out | 3.92e-04 | 19 | 29 | 2 | SM00215 | |
| Domain | - | 4.23e-04 | 95 | 29 | 3 | 2.60.120.200 | |
| Domain | VWC | 1.58e-03 | 38 | 29 | 2 | SM00214 | |
| Domain | Laminin_G_2 | 1.75e-03 | 40 | 29 | 2 | PF02210 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 29 | 2 | IPR001007 | |
| Domain | PSI | 2.11e-03 | 44 | 29 | 2 | IPR016201 | |
| Domain | PSI | 2.31e-03 | 46 | 29 | 2 | SM00423 | |
| Domain | CUB | 2.62e-03 | 49 | 29 | 2 | PF00431 | |
| Domain | CUB | 2.72e-03 | 50 | 29 | 2 | SM00042 | |
| Domain | - | 2.94e-03 | 52 | 29 | 2 | 2.60.120.290 | |
| Domain | CUB | 3.05e-03 | 53 | 29 | 2 | PS01180 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.17e-11 | 13 | 24 | 5 | M47423 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.22e-10 | 27 | 24 | 5 | M39545 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.17e-09 | 12 | 24 | 4 | M47532 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 3.98e-09 | 82 | 24 | 6 | MM15922 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.61e-09 | 84 | 24 | 6 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.08e-09 | 39 | 24 | 5 | MM14604 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.07e-08 | 45 | 24 | 5 | M39571 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.16e-08 | 16 | 24 | 4 | M47424 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.20e-08 | 46 | 24 | 5 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.34e-08 | 47 | 24 | 5 | M7946 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.32e-08 | 59 | 24 | 5 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 4.32e-08 | 59 | 24 | 5 | M17 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.33e-08 | 5 | 24 | 3 | M27411 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.12e-08 | 61 | 24 | 5 | M39540 | |
| Pathway | WP_CANCER_PATHWAYS | 7.57e-08 | 507 | 24 | 9 | M48302 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 8.64e-08 | 6 | 24 | 3 | M27068 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.51e-07 | 7 | 24 | 3 | M27199 | |
| Pathway | WP_FOCAL_ADHESION | 5.55e-07 | 187 | 24 | 6 | MM15913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 7.09e-07 | 11 | 24 | 3 | M47865 | |
| Pathway | WP_FOCAL_ADHESION | 7.99e-07 | 199 | 24 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.99e-07 | 199 | 24 | 6 | M7253 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 9.44e-07 | 12 | 24 | 3 | M47533 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.01e-06 | 46 | 24 | 4 | M239 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.23e-06 | 13 | 24 | 3 | M47534 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.30e-06 | 49 | 24 | 4 | M618 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.41e-06 | 118 | 24 | 5 | M39852 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.95e-06 | 15 | 24 | 3 | M27202 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.75e-06 | 246 | 24 | 6 | M10189 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 2.90e-06 | 17 | 24 | 3 | M39443 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.90e-06 | 17 | 24 | 3 | M39389 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.48e-06 | 18 | 24 | 3 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.13e-06 | 19 | 24 | 3 | MM15594 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.85e-06 | 20 | 24 | 3 | M27881 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.24e-06 | 154 | 24 | 5 | M39739 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.51e-06 | 161 | 24 | 5 | M39770 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 6.54e-06 | 22 | 24 | 3 | M27210 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.64e-06 | 76 | 24 | 4 | M27219 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 8.57e-06 | 24 | 24 | 3 | M11190 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.61e-06 | 300 | 24 | 6 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 8.94e-06 | 302 | 24 | 6 | M39719 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 9.73e-06 | 25 | 24 | 3 | M27879 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.03e-05 | 82 | 24 | 4 | M594 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.38e-05 | 28 | 24 | 3 | M6177 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.38e-05 | 326 | 24 | 6 | MM15917 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.71e-05 | 30 | 24 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.71e-05 | 30 | 24 | 3 | M27216 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.73e-05 | 339 | 24 | 6 | M39736 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.89e-05 | 31 | 24 | 3 | M592 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.29e-05 | 33 | 24 | 3 | M604 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 2.51e-05 | 34 | 24 | 3 | M39390 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.77e-05 | 5 | 24 | 2 | MM14733 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 3.24e-05 | 37 | 24 | 3 | M39506 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.43e-05 | 41 | 24 | 3 | M27778 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.80e-05 | 7 | 24 | 2 | MM14734 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 5.87e-05 | 45 | 24 | 3 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 7.13e-05 | 48 | 24 | 3 | M27642 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.21e-05 | 143 | 24 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 9.93e-05 | 9 | 24 | 2 | M47866 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 1.19e-04 | 57 | 24 | 3 | M48326 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.24e-04 | 10 | 24 | 2 | MM14849 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.26e-04 | 58 | 24 | 3 | M29616 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.32e-04 | 59 | 24 | 3 | M46460 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.51e-04 | 11 | 24 | 2 | M27882 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.51e-04 | 11 | 24 | 2 | M48021 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.51e-04 | 11 | 24 | 2 | M158 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.81e-04 | 12 | 24 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.81e-04 | 12 | 24 | 2 | M22042 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.85e-04 | 66 | 24 | 3 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.02e-04 | 68 | 24 | 3 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.39e-04 | 72 | 24 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.49e-04 | 73 | 24 | 3 | MM15906 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.50e-04 | 14 | 24 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.60e-04 | 74 | 24 | 3 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.15e-04 | 79 | 24 | 3 | M27643 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.56e-04 | 1432 | 24 | 9 | M509 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.77e-04 | 84 | 24 | 3 | M3228 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.91e-04 | 85 | 24 | 3 | M16441 | |
| Pathway | WP_NEPHROGENESIS | 4.18e-04 | 18 | 24 | 2 | M40045 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.18e-04 | 18 | 24 | 2 | MM14775 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.93e-04 | 92 | 24 | 3 | MM14881 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.58e-04 | 96 | 24 | 3 | M39834 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.76e-04 | 97 | 24 | 3 | MM15926 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.29e-04 | 100 | 24 | 3 | M27158 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.48e-04 | 101 | 24 | 3 | M39448 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 6.88e-04 | 23 | 24 | 2 | MM14954 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.45e-04 | 439 | 24 | 5 | M42563 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.76e-04 | 250 | 24 | 4 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.73e-04 | 258 | 24 | 4 | MM14572 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 9.57e-04 | 464 | 24 | 5 | M27547 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.04e-03 | 119 | 24 | 3 | M607 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.25e-03 | 31 | 24 | 2 | MM1343 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.34e-03 | 32 | 24 | 2 | M165 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.42e-03 | 33 | 24 | 2 | M39503 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.42e-03 | 33 | 24 | 2 | M6220 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.78e-03 | 37 | 24 | 2 | M45513 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.05e-03 | 325 | 24 | 4 | M12868 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.40e-03 | 43 | 24 | 2 | M53 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.87e-03 | 47 | 24 | 2 | MM14925 | |
| Pathway | WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY | 2.99e-03 | 48 | 24 | 2 | M39427 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 3.90e-03 | 189 | 24 | 3 | MM14772 | |
| Pubmed | 5.88e-15 | 7 | 29 | 5 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 5.88e-15 | 7 | 29 | 5 | 12846471 | |
| Pubmed | 1.57e-14 | 8 | 29 | 5 | 9858718 | ||
| Pubmed | 3.52e-14 | 9 | 29 | 5 | 11118901 | ||
| Pubmed | 3.52e-14 | 9 | 29 | 5 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 7.04e-14 | 10 | 29 | 5 | 23665443 | |
| Pubmed | 1.29e-13 | 11 | 29 | 5 | 10878608 | ||
| Pubmed | 1.29e-13 | 11 | 29 | 5 | 12866128 | ||
| Pubmed | 2.21e-13 | 12 | 29 | 5 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.59e-13 | 13 | 29 | 5 | 11578869 | |
| Pubmed | 3.90e-13 | 4 | 29 | 4 | 24398584 | ||
| Pubmed | 5.58e-13 | 14 | 29 | 5 | 14757642 | ||
| Pubmed | 8.36e-13 | 15 | 29 | 5 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.22e-12 | 16 | 29 | 5 | 12617809 | |
| Pubmed | 1.22e-12 | 16 | 29 | 5 | 10842072 | ||
| Pubmed | 1.22e-12 | 16 | 29 | 5 | 17273555 | ||
| Pubmed | 1.72e-12 | 17 | 29 | 5 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.72e-12 | 17 | 29 | 5 | 15821257 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 1.95e-12 | 5 | 29 | 4 | 15064243 | |
| Pubmed | 1.95e-12 | 5 | 29 | 4 | 15882997 | ||
| Pubmed | 1.95e-12 | 5 | 29 | 4 | 27118257 | ||
| Pubmed | 2.38e-12 | 18 | 29 | 5 | 18093989 | ||
| Pubmed | 2.38e-12 | 18 | 29 | 5 | 15689374 | ||
| Pubmed | 3.23e-12 | 19 | 29 | 5 | 16518823 | ||
| Pubmed | 5.65e-12 | 21 | 29 | 5 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 5.65e-12 | 21 | 29 | 5 | 14702043 | |
| Pubmed | 5.84e-12 | 6 | 29 | 4 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 5.84e-12 | 6 | 29 | 4 | 12244553 | |
| Pubmed | 9.33e-12 | 23 | 29 | 5 | 14701881 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 1.18e-11 | 24 | 29 | 5 | 21420948 | |
| Pubmed | 1.36e-11 | 7 | 29 | 4 | 10383933 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.82e-11 | 26 | 29 | 5 | 19369401 | |
| Pubmed | 2.72e-11 | 8 | 29 | 4 | 22156581 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 2.72e-11 | 8 | 29 | 4 | 22652674 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 2.72e-11 | 8 | 29 | 4 | 12242716 | |
| Pubmed | 2.72e-11 | 8 | 29 | 4 | 11044610 | ||
| Pubmed | 3.28e-11 | 29 | 29 | 5 | 25535917 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 3.28e-11 | 29 | 29 | 5 | 21402740 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 3.94e-11 | 30 | 29 | 5 | 24552588 | |
| Pubmed | 4.69e-11 | 31 | 29 | 5 | 37573008 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 4.90e-11 | 9 | 29 | 4 | 11944948 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 4.90e-11 | 9 | 29 | 4 | 10837027 | |
| Pubmed | 7.67e-11 | 34 | 29 | 5 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 8.94e-11 | 35 | 29 | 5 | 21252157 | |
| Pubmed | 1.03e-10 | 175 | 29 | 7 | 28071719 | ||
| Pubmed | 1.20e-10 | 37 | 29 | 5 | 24673559 | ||
| Pubmed | 1.20e-10 | 37 | 29 | 5 | 27631609 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.28e-10 | 11 | 29 | 4 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.28e-10 | 11 | 29 | 4 | 15499562 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.28e-10 | 11 | 29 | 4 | 9187150 | |
| Pubmed | 2.06e-10 | 41 | 29 | 5 | 22675208 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.32e-10 | 101 | 29 | 6 | 23382219 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.77e-10 | 13 | 29 | 4 | 31202705 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 2.77e-10 | 13 | 29 | 4 | 20558824 | |
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 2.97e-10 | 44 | 29 | 5 | 17476283 | |
| Pubmed | 3.88e-10 | 14 | 29 | 4 | 18528438 | ||
| Pubmed | 3.88e-10 | 14 | 29 | 4 | 28192800 | ||
| Pubmed | 4.68e-10 | 48 | 29 | 5 | 35247391 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 5.13e-10 | 560 | 29 | 9 | 21653829 | |
| Pubmed | Notch signaling drives multiple myeloma induced osteoclastogenesis. | 5.21e-10 | 3 | 29 | 3 | 25257302 | |
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 26341090 | ||
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 5.21e-10 | 3 | 29 | 3 | 11836628 | |
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 5.21e-10 | 3 | 29 | 3 | 18458347 | |
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 14988227 | ||
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 15939383 | ||
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 5.21e-10 | 3 | 29 | 3 | 10221902 | |
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 5.21e-10 | 3 | 29 | 3 | 37330998 | |
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 5.21e-10 | 3 | 29 | 3 | 14726396 | |
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 5.29e-10 | 15 | 29 | 4 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 5.29e-10 | 15 | 29 | 4 | 16914494 | |
| Pubmed | 5.98e-10 | 118 | 29 | 6 | 21078624 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 7.04e-10 | 16 | 29 | 4 | 27641601 | |
| Pubmed | 7.04e-10 | 16 | 29 | 4 | 32161758 | ||
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 1.18e-09 | 18 | 29 | 4 | 36899896 | |
| Pubmed | 1.50e-09 | 19 | 29 | 4 | 21302255 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 2.08e-09 | 4 | 29 | 3 | 28061457 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 24145721 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 20069356 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 10837254 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 2.08e-09 | 4 | 29 | 3 | 19404845 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 28669409 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 2.08e-09 | 4 | 29 | 3 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 2.08e-09 | 4 | 29 | 3 | 30226866 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 10551863 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 9315665 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 11466531 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 24151014 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 17984306 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 20819128 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 11401408 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 2.08e-09 | 4 | 29 | 3 | 10194420 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 2.08e-09 | 4 | 29 | 3 | 8898100 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 36376768 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 2.08e-09 | 4 | 29 | 3 | 18184405 | |
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 2.08e-09 | 4 | 29 | 3 | 20040020 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 2.08e-09 | 4 | 29 | 3 | 15917835 | |
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 9858728 | ||
| Pubmed | 2.08e-09 | 4 | 29 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 2.08e-09 | 4 | 29 | 3 | 17920003 | |
| Interaction | IGFL3 interactions | 1.01e-13 | 75 | 29 | 8 | int:IGFL3 | |
| Interaction | FBXO2 interactions | JAG2 LRP2 LAMA3 LAMB1 SNED1 LAMC3 ADAM23 LRP1B AGRN NOTCH1 NOTCH2 JAG1 | 1.67e-13 | 411 | 29 | 12 | int:FBXO2 |
| Interaction | ZFP41 interactions | 1.76e-10 | 57 | 29 | 6 | int:ZFP41 | |
| Interaction | NTN5 interactions | 1.79e-10 | 24 | 29 | 5 | int:NTN5 | |
| Interaction | CACNA1A interactions | 1.94e-08 | 123 | 29 | 6 | int:CACNA1A | |
| Interaction | JAG1 interactions | 3.37e-07 | 41 | 29 | 4 | int:JAG1 | |
| Interaction | EDN3 interactions | 4.32e-07 | 108 | 29 | 5 | int:EDN3 | |
| Interaction | JAG2 interactions | 4.73e-07 | 110 | 29 | 5 | int:JAG2 | |
| Interaction | NOTCH3 interactions | 5.41e-07 | 113 | 29 | 5 | int:NOTCH3 | |
| Interaction | HOXA1 interactions | 5.65e-07 | 356 | 29 | 7 | int:HOXA1 | |
| Interaction | WNT3A interactions | 7.00e-07 | 49 | 29 | 4 | int:WNT3A | |
| Interaction | CFC1 interactions | 9.29e-07 | 126 | 29 | 5 | int:CFC1 | |
| Interaction | IGSF5 interactions | 9.65e-07 | 14 | 29 | 3 | int:IGSF5 | |
| Interaction | GFI1B interactions | 1.36e-06 | 136 | 29 | 5 | int:GFI1B | |
| Interaction | MAML2 interactions | 1.80e-06 | 17 | 29 | 3 | int:MAML2 | |
| Interaction | PLAT interactions | 1.94e-06 | 63 | 29 | 4 | int:PLAT | |
| Interaction | CCN6 interactions | 2.56e-06 | 19 | 29 | 3 | int:CCN6 | |
| Interaction | MAML3 interactions | 3.00e-06 | 20 | 29 | 3 | int:MAML3 | |
| Interaction | MBD1 interactions | 4.35e-06 | 77 | 29 | 4 | int:MBD1 | |
| Interaction | ATN1 interactions | 6.46e-06 | 187 | 29 | 5 | int:ATN1 | |
| Interaction | LGALS1 interactions | 6.59e-06 | 332 | 29 | 6 | int:LGALS1 | |
| Interaction | MFNG interactions | 7.66e-06 | 27 | 29 | 3 | int:MFNG | |
| Interaction | ELSPBP1 interactions | 8.85e-06 | 92 | 29 | 4 | int:ELSPBP1 | |
| Interaction | DYRK1A interactions | 1.03e-05 | 552 | 29 | 7 | int:DYRK1A | |
| Interaction | TSHR interactions | 1.05e-05 | 96 | 29 | 4 | int:TSHR | |
| Interaction | ST14 interactions | 1.06e-05 | 207 | 29 | 5 | int:ST14 | |
| Interaction | DAB1 interactions | 1.61e-05 | 107 | 29 | 4 | int:DAB1 | |
| Interaction | ATXN7 interactions | 1.73e-05 | 109 | 29 | 4 | int:ATXN7 | |
| Interaction | WNT10A interactions | 2.01e-05 | 37 | 29 | 3 | int:WNT10A | |
| Interaction | ZDHHC15 interactions | 2.97e-05 | 125 | 29 | 4 | int:ZDHHC15 | |
| Interaction | DLL4 interactions | 2.99e-05 | 6 | 29 | 2 | int:DLL4 | |
| Interaction | TAFA2 interactions | 4.16e-05 | 47 | 29 | 3 | int:TAFA2 | |
| Interaction | PATE1 interactions | 4.72e-05 | 49 | 29 | 3 | int:PATE1 | |
| Interaction | DKK2 interactions | 4.72e-05 | 49 | 29 | 3 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 4.72e-05 | 49 | 29 | 3 | int:FOXD4L6 | |
| Interaction | PRG2 interactions | 4.91e-05 | 285 | 29 | 5 | int:PRG2 | |
| Interaction | SLURP1 interactions | 5.17e-05 | 144 | 29 | 4 | int:SLURP1 | |
| Interaction | MFAP5 interactions | 5.65e-05 | 52 | 29 | 3 | int:MFAP5 | |
| Interaction | SERPINE1 interactions | 6.32e-05 | 54 | 29 | 3 | int:SERPINE1 | |
| Interaction | SMOC1 interactions | 6.32e-05 | 54 | 29 | 3 | int:SMOC1 | |
| Interaction | SHANK3 interactions | 6.33e-05 | 496 | 29 | 6 | int:SHANK3 | |
| Interaction | LYPD1 interactions | 7.84e-05 | 58 | 29 | 3 | int:LYPD1 | |
| Interaction | ANKRD36B interactions | 8.68e-05 | 60 | 29 | 3 | int:ANKRD36B | |
| Interaction | MANEA interactions | 8.68e-05 | 60 | 29 | 3 | int:MANEA | |
| Interaction | SDF2L1 interactions | 8.75e-05 | 322 | 29 | 5 | int:SDF2L1 | |
| Interaction | PTPRK interactions | 1.15e-04 | 177 | 29 | 4 | int:PTPRK | |
| Interaction | MFAP2 interactions | 1.31e-04 | 12 | 29 | 2 | int:MFAP2 | |
| Interaction | SCGB1A1 interactions | 1.31e-04 | 12 | 29 | 2 | int:SCGB1A1 | |
| Interaction | CNTN1 interactions | 1.32e-04 | 69 | 29 | 3 | int:CNTN1 | |
| Interaction | MAML1 interactions | 1.56e-04 | 73 | 29 | 3 | int:MAML1 | |
| Interaction | APBB1 interactions | 1.67e-04 | 195 | 29 | 4 | int:APBB1 | |
| Interaction | RNASE4 interactions | 1.80e-04 | 14 | 29 | 2 | int:RNASE4 | |
| Interaction | LFNG interactions | 1.80e-04 | 14 | 29 | 2 | int:LFNG | |
| Interaction | EGFL7 interactions | 1.82e-04 | 77 | 29 | 3 | int:EGFL7 | |
| Interaction | CRP interactions | 1.82e-04 | 77 | 29 | 3 | int:CRP | |
| Interaction | CUBN interactions | 2.08e-04 | 15 | 29 | 2 | int:CUBN | |
| Interaction | SCN3A interactions | 2.37e-04 | 16 | 29 | 2 | int:SCN3A | |
| Interaction | LRP1B interactions | 2.44e-04 | 85 | 29 | 3 | int:LRP1B | |
| Interaction | LY86 interactions | 2.51e-04 | 217 | 29 | 4 | int:LY86 | |
| Interaction | NID2 interactions | 2.53e-04 | 86 | 29 | 3 | int:NID2 | |
| Interaction | SIRPD interactions | 2.53e-04 | 86 | 29 | 3 | int:SIRPD | |
| Interaction | PSEN2 interactions | 2.53e-04 | 86 | 29 | 3 | int:PSEN2 | |
| Interaction | OS9 interactions | 2.60e-04 | 219 | 29 | 4 | int:OS9 | |
| Interaction | TIMP3 interactions | 2.89e-04 | 90 | 29 | 3 | int:TIMP3 | |
| Interaction | MDK interactions | 2.99e-04 | 91 | 29 | 3 | int:MDK | |
| Interaction | OLFM3 interactions | 3.02e-04 | 18 | 29 | 2 | int:OLFM3 | |
| Interaction | NOTCH2 interactions | 3.12e-04 | 423 | 29 | 5 | int:NOTCH2 | |
| Interaction | DEFB125 interactions | 3.74e-04 | 20 | 29 | 2 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 3.74e-04 | 20 | 29 | 2 | int:ZNF224 | |
| Interaction | CLU interactions | 3.99e-04 | 245 | 29 | 4 | int:CLU | |
| Interaction | NOTCH4 interactions | 4.13e-04 | 21 | 29 | 2 | int:NOTCH4 | |
| Interaction | EGFL6 interactions | 4.13e-04 | 21 | 29 | 2 | int:EGFL6 | |
| Interaction | CASR interactions | 4.54e-04 | 22 | 29 | 2 | int:CASR | |
| Interaction | ZNF431 interactions | 4.54e-04 | 22 | 29 | 2 | int:ZNF431 | |
| Interaction | DTX4 interactions | 4.54e-04 | 22 | 29 | 2 | int:DTX4 | |
| Interaction | WNT2 interactions | 4.96e-04 | 23 | 29 | 2 | int:WNT2 | |
| Interaction | SCARF2 interactions | 5.41e-04 | 24 | 29 | 2 | int:SCARF2 | |
| Interaction | WNT10B interactions | 5.88e-04 | 25 | 29 | 2 | int:WNT10B | |
| Interaction | COL6A1 interactions | 6.24e-04 | 117 | 29 | 3 | int:COL6A1 | |
| Interaction | SEC61B interactions | 6.50e-04 | 763 | 29 | 6 | int:SEC61B | |
| Interaction | GIPC1 interactions | 6.56e-04 | 119 | 29 | 3 | int:GIPC1 | |
| Interaction | SULF2 interactions | 6.56e-04 | 119 | 29 | 3 | int:SULF2 | |
| Interaction | NTF3 interactions | 6.86e-04 | 27 | 29 | 2 | int:NTF3 | |
| Interaction | FEZF1 interactions | 7.38e-04 | 28 | 29 | 2 | int:FEZF1 | |
| Interaction | GLI4 interactions | 7.57e-04 | 125 | 29 | 3 | int:GLI4 | |
| Interaction | THBS1 interactions | 7.92e-04 | 127 | 29 | 3 | int:THBS1 | |
| Interaction | ZNF517 interactions | 7.92e-04 | 29 | 29 | 2 | int:ZNF517 | |
| Interaction | CILP2 interactions | 9.06e-04 | 31 | 29 | 2 | int:CILP2 | |
| Interaction | PLAUR interactions | 9.46e-04 | 135 | 29 | 3 | int:PLAUR | |
| Interaction | TMEM106B interactions | 9.51e-04 | 309 | 29 | 4 | int:TMEM106B | |
| Interaction | ITGB1BP1 interactions | 1.03e-03 | 33 | 29 | 2 | int:ITGB1BP1 | |
| Interaction | B3GALT4 interactions | 1.03e-03 | 33 | 29 | 2 | int:B3GALT4 | |
| Interaction | ANKS1B interactions | 1.09e-03 | 34 | 29 | 2 | int:ANKS1B | |
| Interaction | ZNF74 interactions | 1.09e-03 | 34 | 29 | 2 | int:ZNF74 | |
| Interaction | NXPH4 interactions | 1.09e-03 | 34 | 29 | 2 | int:NXPH4 | |
| Interaction | DTX1 interactions | 1.16e-03 | 35 | 29 | 2 | int:DTX1 | |
| Interaction | LPL interactions | 1.16e-03 | 35 | 29 | 2 | int:LPL | |
| Interaction | ZNF408 interactions | 1.16e-03 | 145 | 29 | 3 | int:ZNF408 | |
| Interaction | CLEC2B interactions | 1.21e-03 | 147 | 29 | 3 | int:CLEC2B | |
| Interaction | DLK2 interactions | 1.22e-03 | 36 | 29 | 2 | int:DLK2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.38e-03 | 423 | 29 | 3 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 8.91e-03 | 681 | 29 | 3 | chr1p36 | |
| GeneFamily | Laminin subunits | 2.53e-07 | 12 | 20 | 3 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 3.29e-07 | 13 | 20 | 3 | 634 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.01e-04 | 27 | 20 | 2 | 1253 | |
| GeneFamily | Ankyrin repeat domain containing | 2.28e-03 | 242 | 20 | 3 | 403 | |
| GeneFamily | Fibronectin type III domain containing | 1.33e-02 | 160 | 20 | 2 | 555 | |
| Coexpression | NABA_MATRISOME | LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 TNC AGRN MEGF11 MEGF10 CELA2A | 6.41e-13 | 1008 | 29 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | LAMA3 CRELD2 LAMB1 SNED1 LAMC3 OIT3 EGF MEGF6 ADAM23 TNC AGRN MEGF11 MEGF10 CELA2A | 8.14e-13 | 1026 | 29 | 14 | M5889 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.99e-12 | 16 | 29 | 5 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.99e-12 | 16 | 29 | 5 | MM1296 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.58e-11 | 191 | 29 | 8 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.18e-11 | 196 | 29 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 4.07e-10 | 270 | 29 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.70e-10 | 275 | 29 | 8 | M5884 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 6.79e-08 | 8 | 29 | 3 | M9884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.07e-07 | 40 | 29 | 4 | M5887 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.15e-07 | 365 | 29 | 7 | M39018 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 1.31e-07 | 42 | 29 | 4 | M5895 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS | 4.26e-07 | 56 | 29 | 4 | M40224 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 2.76e-06 | 25 | 29 | 3 | M9946 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 3.20e-06 | 600 | 29 | 7 | M39055 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 5.91e-06 | 32 | 29 | 3 | M5903 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.03e-05 | 163 | 29 | 4 | M12112 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS | 5.08e-05 | 65 | 29 | 3 | M40266 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 5.92e-05 | 385 | 29 | 5 | M39264 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 6.46e-05 | 11 | 29 | 2 | M566 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 6.73e-05 | 200 | 29 | 4 | M5930 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 7.75e-05 | 12 | 29 | 2 | M17374 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 8.43e-05 | 77 | 29 | 3 | M40001 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.58e-05 | 681 | 29 | 6 | M39175 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 9.45e-05 | 80 | 29 | 3 | M15368 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.10e-04 | 439 | 29 | 5 | M39054 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.33e-04 | 738 | 29 | 6 | MM17058 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.34e-04 | 1074 | 29 | 7 | M1941 | |
| Coexpression | LEE_LIVER_CANCER_HEPATOBLAST | 1.40e-04 | 16 | 29 | 2 | M13123 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.47e-04 | 751 | 29 | 6 | M5885 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 1.79e-04 | 18 | 29 | 2 | M3506 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.88e-04 | 261 | 29 | 4 | M1834 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.00e-04 | 795 | 29 | 6 | M39050 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 2.12e-04 | 105 | 29 | 3 | M12602 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 2.22e-04 | 20 | 29 | 2 | M17175 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.22e-04 | 20 | 29 | 2 | MM17053 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 2.45e-04 | 21 | 29 | 2 | M16756 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 3.80e-04 | 574 | 29 | 5 | M39056 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 3.96e-04 | 130 | 29 | 3 | M40147 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 4.05e-04 | 131 | 29 | 3 | M39232 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 4.31e-04 | 325 | 29 | 4 | M39053 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 4.43e-04 | 135 | 29 | 3 | M5825 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 4.48e-04 | 595 | 29 | 5 | M40167 | |
| Coexpression | PDGF_UP.V1_DN | 4.52e-04 | 136 | 29 | 3 | M2832 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 4.71e-04 | 29 | 29 | 2 | M47987 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.71e-04 | 29 | 29 | 2 | MM17055 | |
| Coexpression | NABA_SECRETED_FACTORS | 5.00e-04 | 338 | 29 | 4 | MM17064 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 5.03e-04 | 141 | 29 | 3 | M2901 | |
| Coexpression | NABA_SECRETED_FACTORS | 5.28e-04 | 343 | 29 | 4 | M5883 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 5.39e-04 | 31 | 29 | 2 | M1291 | |
| Coexpression | DASU_IL6_SIGNALING_SCAR_UP | 5.39e-04 | 31 | 29 | 2 | M292 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 6.47e-04 | 362 | 29 | 4 | M39176 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 6.49e-04 | 34 | 29 | 2 | M1263 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 6.88e-04 | 35 | 29 | 2 | M16637 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.88e-04 | 35 | 29 | 2 | MM17054 | |
| Coexpression | HALLMARK_ANGIOGENESIS | 7.27e-04 | 36 | 29 | 2 | M5944 | |
| Coexpression | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS | 7.69e-04 | 37 | 29 | 2 | M12802 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 7.69e-04 | 37 | 29 | 2 | M16643 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 7.69e-04 | 37 | 29 | 2 | MM1121 | |
| Coexpression | HUANG_FOXA2_TARGETS_DN | 8.11e-04 | 38 | 29 | 2 | M16701 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 8.36e-04 | 168 | 29 | 3 | M1124 | |
| Coexpression | GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 8.65e-04 | 170 | 29 | 3 | M6855 | |
| Coexpression | NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP | 8.98e-04 | 40 | 29 | 2 | M40897 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 9.41e-04 | 175 | 29 | 3 | M6723 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 9.44e-04 | 41 | 29 | 2 | M47988 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 9.56e-04 | 176 | 29 | 3 | M9032 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.04e-03 | 43 | 29 | 2 | MM666 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.04e-03 | 43 | 29 | 2 | M1551 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.05e-03 | 182 | 29 | 3 | MM993 | |
| Coexpression | MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS | 1.09e-03 | 44 | 29 | 2 | M39252 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 1.10e-03 | 418 | 29 | 4 | M12676 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 1.16e-03 | 188 | 29 | 3 | M7940 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN | 1.19e-03 | 46 | 29 | 2 | M6679 | |
| Coexpression | JIANG_TIP30_TARGETS_UP | 1.19e-03 | 46 | 29 | 2 | M12641 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP | 1.21e-03 | 191 | 29 | 3 | M4722 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.25e-03 | 432 | 29 | 4 | MM419 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 1.26e-03 | 433 | 29 | 4 | M2240 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.27e-03 | 194 | 29 | 3 | M39122 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 1.28e-03 | 435 | 29 | 4 | MM1221 | |
| Coexpression | LTE2_UP.V1_DN | 1.28e-03 | 195 | 29 | 3 | M2721 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 1.29e-03 | 48 | 29 | 2 | M1246 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.29e-03 | 48 | 29 | 2 | MM531 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 1.30e-03 | 196 | 29 | 3 | M2445 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 1.32e-03 | 197 | 29 | 3 | MM1320 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.33e-03 | 440 | 29 | 4 | M39039 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 1.34e-03 | 198 | 29 | 3 | M9778 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN | 1.36e-03 | 199 | 29 | 3 | M8641 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.36e-03 | 199 | 29 | 3 | M5406 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN | 1.36e-03 | 199 | 29 | 3 | M8385 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.36e-03 | 199 | 29 | 3 | M3912 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M8553 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 1.38e-03 | 200 | 29 | 3 | M7283 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN | 1.38e-03 | 200 | 29 | 3 | M9935 | |
| Coexpression | GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 1.38e-03 | 200 | 29 | 3 | M7758 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 1.38e-03 | 200 | 29 | 3 | M8648 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 1.38e-03 | 200 | 29 | 3 | M9370 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M6263 | |
| Coexpression | GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP | 1.38e-03 | 200 | 29 | 3 | M6790 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP | 1.38e-03 | 200 | 29 | 3 | M8517 | |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M8521 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 9.10e-06 | 370 | 29 | 6 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 1.38e-05 | 398 | 29 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 6.59e-05 | 777 | 29 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 6.92e-05 | 783 | 29 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 7.17e-05 | 165 | 29 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 7.35e-05 | 166 | 29 | 4 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.19e-04 | 362 | 29 | 5 | JC_hmvEC_2500_K3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | 2.81e-04 | 981 | 29 | 7 | Arv_EB-LF_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.10e-04 | 445 | 29 | 5 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 3.26e-04 | 450 | 29 | 5 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.43e-04 | 455 | 29 | 5 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 3.47e-04 | 456 | 29 | 5 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 3.57e-04 | 459 | 29 | 5 | GSM777037_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 4.48e-04 | 749 | 29 | 6 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 5.11e-04 | 768 | 29 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 5.29e-04 | 773 | 29 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 5.49e-04 | 281 | 29 | 4 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 5.49e-04 | 281 | 29 | 4 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 5.86e-04 | 1466 | 29 | 8 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 5.92e-04 | 121 | 29 | 3 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 6.21e-04 | 123 | 29 | 3 | gudmap_kidney_P3_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 6.26e-04 | 291 | 29 | 4 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 6.60e-04 | 806 | 29 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-09 | 191 | 29 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.16e-07 | 183 | 29 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-07 | 183 | 29 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 185 | 29 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-07 | 189 | 29 | 5 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-07 | 190 | 29 | 5 | 632d5dc11765053366d61f0a0c7916111cea4f50 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 190 | 29 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 190 | 29 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 190 | 29 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-07 | 191 | 29 | 5 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-07 | 192 | 29 | 5 | 5012cc3ec0766f06af447463413422b484446c43 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 193 | 29 | 5 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 193 | 29 | 5 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 193 | 29 | 5 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.55e-07 | 194 | 29 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-07 | 195 | 29 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.59e-07 | 195 | 29 | 5 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-07 | 196 | 29 | 5 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-07 | 196 | 29 | 5 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-07 | 197 | 29 | 5 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-07 | 197 | 29 | 5 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-07 | 197 | 29 | 5 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 198 | 29 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-07 | 199 | 29 | 5 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.50e-06 | 161 | 29 | 4 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.86e-06 | 165 | 29 | 4 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 171 | 29 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 171 | 29 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.44e-06 | 171 | 29 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.55e-06 | 172 | 29 | 4 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 175 | 29 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 175 | 29 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.98e-06 | 176 | 29 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-06 | 181 | 29 | 4 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-06 | 184 | 29 | 4 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.94e-06 | 184 | 29 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.06e-06 | 185 | 29 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 186 | 29 | 4 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-06 | 187 | 29 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-06 | 187 | 29 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-06 | 187 | 29 | 4 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 187 | 29 | 4 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 188 | 29 | 4 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.46e-06 | 188 | 29 | 4 | 59f276e23c8380bae57d7ecca3a8b83df4bc150b | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 188 | 29 | 4 | b294d6658e79328bd6fa33223e8c70117ba9789b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-06 | 188 | 29 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 189 | 29 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 189 | 29 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 189 | 29 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-06 | 189 | 29 | 4 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 189 | 29 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 189 | 29 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 189 | 29 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-06 | 189 | 29 | 4 | 1e1afa66b32ae752c0a42b02b80f10205464569c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 189 | 29 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 6.74e-06 | 190 | 29 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 190 | 29 | 4 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.74e-06 | 190 | 29 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-06 | 191 | 29 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.88e-06 | 191 | 29 | 4 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.88e-06 | 191 | 29 | 4 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.88e-06 | 191 | 29 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-06 | 191 | 29 | 4 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.88e-06 | 191 | 29 | 4 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.88e-06 | 191 | 29 | 4 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-06 | 191 | 29 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 29 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 29 | 4 | f68e6cbde87678122da1b5c0061904cfb7d04bf5 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-06 | 192 | 29 | 4 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 29 | 4 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 29 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 29 | 4 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-06 | 192 | 29 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-06 | 192 | 29 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 29 | 4 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 29 | 4 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.02e-06 | 192 | 29 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 29 | 4 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 29 | 4 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.17e-06 | 193 | 29 | 4 | 2661ad9107ed9231e4afea4442a79051139a31df | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.17e-06 | 193 | 29 | 4 | d338a7c0585b69947c37f44aa0381619493e31ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-06 | 193 | 29 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-06 | 193 | 29 | 4 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.17e-06 | 193 | 29 | 4 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-06 | 193 | 29 | 4 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| Computational | Adhesion molecules. | 1.73e-04 | 141 | 22 | 4 | MODULE_122 | |
| Computational | Intermediate filaments and MT. | 3.42e-04 | 68 | 22 | 3 | MODULE_438 | |
| Computational | Genes in the cancer module 275. | 4.72e-04 | 16 | 22 | 2 | MODULE_275 | |
| Computational | Developmental processes. | 4.72e-04 | 333 | 22 | 5 | MODULE_220 | |
| Drug | lead stearate | 6.71e-08 | 84 | 29 | 5 | CID000061258 | |
| Drug | LMWH | 8.48e-08 | 663 | 29 | 9 | CID000000772 | |
| Drug | AC1L1G72 | 3.04e-07 | 11 | 29 | 3 | CID000003553 | |
| Drug | Rgd Peptide | 4.88e-07 | 239 | 29 | 6 | CID000104802 | |
| Drug | kalinin | 6.92e-07 | 55 | 29 | 4 | CID000032518 | |
| Drug | anad | 8.37e-07 | 15 | 29 | 3 | CID005287574 | |
| Drug | LG 5 | 9.85e-07 | 60 | 29 | 4 | CID011840957 | |
| Drug | napabucasin | 1.28e-06 | 64 | 29 | 4 | ctd:C000621033 | |
| Drug | dysprosium | 2.30e-06 | 74 | 29 | 4 | CID000023912 | |
| Drug | 2-amino-5-methylpyridine | 2.69e-06 | 77 | 29 | 4 | CID000015348 | |
| Drug | Sikvav | 3.69e-06 | 24 | 29 | 3 | CID005487517 | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 4.51e-06 | 196 | 29 | 5 | 6715_UP | |
| Drug | monatepil | 6.64e-06 | 29 | 29 | 3 | CID000060810 | |
| Drug | AC1L1B58 | 6.64e-06 | 29 | 29 | 3 | CID000001288 | |
| Drug | colchine | 7.46e-06 | 383 | 29 | 6 | CID000002833 | |
| Drug | chondroitin sulfate | 1.15e-05 | 413 | 29 | 6 | CID000024766 | |
| Drug | B-Ms | 1.29e-05 | 114 | 29 | 4 | CID000445091 | |
| Drug | Calcort | 1.52e-05 | 38 | 29 | 3 | CID000026709 | |
| Drug | AC1L1B6T | 1.52e-05 | 38 | 29 | 3 | CID000001308 | |
| Drug | D 247 | 1.56e-05 | 5 | 29 | 2 | CID003048156 | |
| Drug | AC1O0B8G | 1.84e-05 | 262 | 29 | 5 | CID000091605 | |
| Drug | enzacamene | 2.09e-05 | 129 | 29 | 4 | ctd:C038939 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 2.38e-05 | 44 | 29 | 3 | ctd:C419410 | |
| Drug | Reidispongiolide C | 2.49e-05 | 279 | 29 | 5 | CID005289285 | |
| Drug | octylmethoxycinnamate | 2.81e-05 | 139 | 29 | 4 | ctd:C118580 | |
| Drug | AC1L1JJ0 | 3.28e-05 | 7 | 29 | 2 | CID000005061 | |
| Drug | Jmv 320 | 3.28e-05 | 7 | 29 | 2 | CID003081775 | |
| Drug | AC1L1GUQ | 3.50e-05 | 50 | 29 | 3 | CID000003849 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.30e-05 | 155 | 29 | 4 | 6817_DN | |
| Drug | AC1L1KKK | 4.37e-05 | 8 | 29 | 2 | CID000005539 | |
| Drug | I-Q-S | 4.41e-05 | 156 | 29 | 4 | CID000003540 | |
| Drug | 2,4-diaminopyrimidine | 4.41e-05 | 54 | 29 | 3 | CID000067431 | |
| Drug | butylparaben | 4.52e-05 | 157 | 29 | 4 | ctd:C038091 | |
| Drug | 25-hydroxycholesterol | 4.86e-05 | 160 | 29 | 4 | CID000065094 | |
| Drug | probucol | 5.11e-05 | 162 | 29 | 4 | CID000004912 | |
| Drug | coprogen | 5.61e-05 | 9 | 29 | 2 | CID006323272 | |
| Drug | A-state | 5.61e-05 | 9 | 29 | 2 | CID005460479 | |
| Drug | CC270 | 5.76e-05 | 59 | 29 | 3 | CID006918852 | |
| Drug | AC1L9INI | 5.76e-05 | 59 | 29 | 3 | CID000445839 | |
| Drug | Epi Lovastatin | 6.47e-05 | 341 | 29 | 5 | CID000003962 | |
| Drug | A25152 | 6.68e-05 | 62 | 29 | 3 | CID000002956 | |
| Drug | 25-azacoprostane | 7.00e-05 | 10 | 29 | 2 | CID000162243 | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 7.00e-05 | 10 | 29 | 2 | ctd:C028145 | |
| Drug | sagamicin | 7.00e-05 | 10 | 29 | 2 | CID000107677 | |
| Drug | BM165 | 8.55e-05 | 11 | 29 | 2 | CID003352881 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 8.73e-05 | 186 | 29 | 4 | 4271_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 1.01e-04 | 193 | 29 | 4 | 1896_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 6739_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 5771_UP | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6380_UP | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 4629_DN | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6728_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 5069_UP | |
| Drug | isocycloheximide | 1.11e-04 | 905 | 29 | 7 | CID000002900 | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5545_DN | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6384_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5996_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5425_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 3202_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 6836_UP | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 6075_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 6450_UP | |
| Drug | Androgen Antagonists | 1.18e-04 | 75 | 29 | 3 | ctd:D000726 | |
| Drug | YIGSR | 1.38e-04 | 79 | 29 | 3 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.59e-04 | 83 | 29 | 3 | CID011968896 | |
| Drug | 1-Methyl-3-isobutylxanthine | 1.61e-04 | 414 | 29 | 5 | ctd:D015056 | |
| Drug | NSC 714187 | 1.71e-04 | 85 | 29 | 3 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 1.77e-04 | 86 | 29 | 3 | CID000001322 | |
| Drug | H-9 dihydrochloride | 2.03e-04 | 90 | 29 | 3 | CID000003544 | |
| Drug | tranylcypromine | 2.09e-04 | 91 | 29 | 3 | CID000005530 | |
| Drug | butylphen | 2.11e-04 | 17 | 29 | 2 | ctd:C006862 | |
| Drug | ALT-711 | 3.24e-04 | 21 | 29 | 2 | CID000216304 | |
| Drug | hyaluronan | 3.29e-04 | 263 | 29 | 4 | CID000024759 | |
| Drug | MRK 003 | 3.34e-04 | 760 | 29 | 6 | ctd:C523799 | |
| Drug | sterol | 3.39e-04 | 265 | 29 | 4 | CID000001107 | |
| Drug | butyrate | 3.51e-04 | 767 | 29 | 6 | CID000000264 | |
| Drug | prochloraz | 3.54e-04 | 268 | 29 | 4 | ctd:C045362 | |
| Drug | Gdrgdsp | 3.56e-04 | 109 | 29 | 3 | CID000115346 | |
| Drug | AC1L1C2F | 3.66e-04 | 110 | 29 | 3 | CID000001711 | |
| Drug | pitavastatin | 4.06e-04 | 114 | 29 | 3 | CID005282451 | |
| Drug | tyrphostin RG13022 | 4.61e-04 | 25 | 29 | 2 | CID000005060 | |
| Drug | tyrphostin AG 1478 | 4.95e-04 | 122 | 29 | 3 | ctd:C101044 | |
| Drug | iodide | 5.19e-04 | 534 | 29 | 5 | CID000024841 | |
| Drug | Linuron | 5.70e-04 | 128 | 29 | 3 | ctd:D008044 | |
| Disease | Carcinoma, Pancreatic Ductal | 7.88e-09 | 24 | 29 | 4 | C0887833 | |
| Disease | Glioblastoma | 1.37e-08 | 79 | 29 | 5 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.86e-08 | 84 | 29 | 5 | C0334588 | |
| Disease | Glioblastoma Multiforme | 7.60e-08 | 111 | 29 | 5 | C1621958 | |
| Disease | Hepatic ductular hypoplasia | 9.33e-07 | 2 | 29 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 9.33e-07 | 2 | 29 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 9.33e-07 | 2 | 29 | 2 | C1857761 | |
| Disease | Alagille Syndrome | 9.33e-07 | 2 | 29 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 9.33e-07 | 2 | 29 | 2 | cv:C0085280 | |
| Disease | Alagille Syndrome 1 | 9.33e-07 | 2 | 29 | 2 | C1956125 | |
| Disease | Mammary Carcinoma, Human | 1.03e-05 | 525 | 29 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.03e-05 | 525 | 29 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 1.06e-05 | 527 | 29 | 6 | C1458155 | |
| Disease | Breast Carcinoma | 1.19e-05 | 538 | 29 | 6 | C0678222 | |
| Disease | Schizophrenia | 1.84e-05 | 883 | 29 | 7 | C0036341 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.95e-05 | 7 | 29 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.95e-05 | 7 | 29 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 2.67e-05 | 59 | 29 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.67e-05 | 59 | 29 | 3 | C0037286 | |
| Disease | hemangiopericytoma (is_marker_for) | 3.34e-05 | 9 | 29 | 2 | DOID:264 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 7.23e-05 | 13 | 29 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 9.72e-05 | 15 | 29 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 9.72e-05 | 15 | 29 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 9.72e-05 | 15 | 29 | 2 | C0154091 | |
| Disease | cancer (implicated_via_orthology) | 1.32e-04 | 268 | 29 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | Carcinoma of bladder | 1.41e-04 | 18 | 29 | 2 | C0699885 | |
| Disease | Squamous cell carcinoma | 2.44e-04 | 124 | 29 | 3 | C0007137 | |
| Disease | congenital heart disease (is_implicated_in) | 2.54e-04 | 24 | 29 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Cerebral Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0334583 | |
| Disease | Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.76e-04 | 25 | 29 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 2.76e-04 | 25 | 29 | 2 | C0338070 | |
| Disease | brain cancer (implicated_via_orthology) | 2.99e-04 | 26 | 29 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 2.99e-04 | 26 | 29 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.99e-04 | 26 | 29 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.99e-04 | 26 | 29 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 3.22e-04 | 27 | 29 | 2 | C0334579 | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.99e-04 | 30 | 29 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 4.54e-04 | 32 | 29 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 4.79e-04 | 156 | 29 | 3 | C0376634 | |
| Disease | lupus nephritis | 4.83e-04 | 33 | 29 | 2 | EFO_0005761 | |
| Disease | pack-years measurement, systolic blood pressure | 5.13e-04 | 34 | 29 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | cervical cancer | 5.13e-04 | 34 | 29 | 2 | C4048328 | |
| Disease | Malignant neoplasm of breast | 5.31e-04 | 1074 | 29 | 6 | C0006142 | |
| Disease | endometrial cancer (is_marker_for) | 5.44e-04 | 35 | 29 | 2 | DOID:1380 (is_marker_for) | |
| Disease | Uterine Cervical Neoplasm | 5.44e-04 | 35 | 29 | 2 | C0007873 | |
| Disease | response to radiation, prostate carcinoma, erectile dysfunction | 6.08e-04 | 37 | 29 | 2 | EFO_0001663, EFO_0004234, GO_0009314 | |
| Disease | Lymphoma | 7.11e-04 | 40 | 29 | 2 | C0024299 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.47e-04 | 41 | 29 | 2 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.47e-04 | 41 | 29 | 2 | C0858252 | |
| Disease | rectum cancer | 7.84e-04 | 42 | 29 | 2 | EFO_1000657 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.14e-04 | 447 | 29 | 4 | EFO_0000694, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGAHCSDGPCCNNTS | 536 | O75077 | |
| SACQCNPHGSYGGTC | 791 | O00468 | |
| SCNGDSGGPLNCQAS | 211 | P08217 | |
| CQCHNGGTCDAATGQ | 281 | Q96KG7 | |
| GGTCDAATGQCHCSP | 286 | Q96KG7 | |
| SGCASSPCQHGGSCH | 1376 | Q04721 | |
| HNGGQCSPTTGACEC | 321 | A6BM72 | |
| DSQPCLHGGTCQDGC | 1026 | P46531 | |
| NHCSNYCQNGGTCVP | 4251 | Q9NZR2 | |
| TGRCVPCNCNGHSNQ | 1681 | Q16787 | |
| PCNCNGHSNQCQDGS | 1686 | Q16787 | |
| GGSCQPCSCNSNGQL | 1781 | Q16787 | |
| PCSCNSNGQLGSCHP | 1786 | Q16787 | |
| CTSNPCANGGSCHEV | 351 | Q9Y219 | |
| LCDQCSLNNGGCSHN | 1181 | Q07954 | |
| APSCLTCVGHCSNGG | 4371 | Q07954 | |
| GCHNNNGGCSHSCLG | 226 | Q8WWZ8 | |
| ASGTGCDPCNCNAAH | 1076 | P07942 | |
| CNSVCFGDHTQPCGG | 186 | Q96MU8 | |
| PLCNGNSCSDFNGGC | 1346 | P98164 | |
| SNPCGTNNGGCSHLC | 3466 | P98164 | |
| NGTGPLCSGKGHCQC | 531 | P26010 | |
| GHCQCGRCSCSGQSS | 541 | P26010 | |
| CSGCSSPDNGGCSQL | 436 | P01133 | |
| PTNGGQCTACTCSGH | 1051 | Q5VV63 | |
| AGDNSCKSNPCHNGG | 886 | P82279 | |
| NVCNSNPCLHGGNCE | 1141 | P82279 | |
| QGGSQRPCSGNGHCS | 141 | Q6UXH1 | |
| DDCSPNNCSHGGTCQ | 376 | P78504 | |
| CASNPCLNGGHCQNE | 491 | P78504 | |
| CSQNPCHNGGTCRDL | 671 | P78504 | |
| CLCQNGGTCDPVSGH | 1046 | O75095 | |
| SCRNGGLCHASNGSC | 1306 | O75095 | |
| GLCHASNGSCSCGLG | 1311 | O75095 | |
| TACHSGPCLNGGSCN | 731 | Q99466 | |
| CNASCPAGFHGNNCS | 381 | Q14162 | |
| DSCASGPCHNGGTCF | 621 | Q8TER0 | |
| CNGNFSGHNCGTCRP | 101 | P17643 | |
| SCPNDCHGQGRCVNG | 531 | P24821 | |
| GLDCGQHSCPSDCNN | 586 | P24821 | |
| QNCNTGSSGCCENSG | 191 | Q5T750 | |
| PCTCNQHGTCDPNTG | 706 | Q9Y6N6 | |
| GLCAPCGQLNTTCGG | 466 | Q14533 |